Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2020-10-15
2022-01-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Pectointercostal+ESP Block on Postoperatif Analgesia in Open Heart Surgery
NCT05590013
Comparison of the Effect of Preemptive and Post-operative Erector Spina Plane Block on Intraoperative Opioid Consumption and Postoperative Analgesia in Patients Who Will Undergo Elective Thoracotomy Surgery, Guided by the Nociception Level Index (NoL)
NCT05944523
Comparison of Analgesic Efficacy in Video-Assisted Thoracoscopic Surgery Patients
NCT06352398
Bilateral Erector Spina Block Versus Parasternal Block in Adult Heart Surgery
NCT04090099
Transversus Thoracis Muscle Plane Block for Postoperative Pain in Adult Cardiac Surgery
NCT04591119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PVB Group
Paravertebral block administered group
PVB
Paravertebral block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.
ESPB group
Erector spinae plane block administered group
ESPB
Erector spinae plane block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PVB
Paravertebral block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.
ESPB
Erector spinae plane block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Infection of the skin at the site of the needle puncture area
* Patients with known allergies to any of the study drugs
* Coagulopathy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mustafa Duran
MD, Principal investigator.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kocaeli Unversity
Kocaeli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GOKAEK-2020/18.09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.